Israel plans to occupy Gaza City, disarm Hamas, and transfer control to Arab forces, raising concerns over humanitarian risks and hostage safety.
Firefly Aerospace's successful Nasdaq debut, raising $868M and reaching a valuation close to $10B, reflects strong investor enthusiasm for its space technology.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise despite higher R&D expenses and a decline in operating margin.
Israel plans to occupy Gaza City, disarm Hamas, and transfer control to Arab forces, raising concerns over humanitarian risks and hostage safety.
Firefly Aerospace's successful Nasdaq debut, raising $868M and reaching a valuation close to $10B, reflects strong investor enthusiasm for its space technology.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise despite higher R&D expenses and a decline in operating margin.